6-Chloro-4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide(CAS: 70374-39-9)
![6-Chloro-4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide 6-Chloro-4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide](https://cnstatic.chemtradehub.com/structs/703/70374-39-9-17cd.webp)
CAS号
相关产品
(2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22S,34S,37R,40R,52S)-5,32-dichloro-52-[3-(dimethylamino)propylcarbamoyl]-2,26,31,44,49-pentahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,65-henicosaen-64-yl]oxy]-3,4-dihydroxy-5-(10-methylundecanoylamino)oxane-2-carboxylic acid
CAS号: 171500-79-1
其他供应商提供的 6-Chloro-4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-thieno[2,3-e][1,2]thiazine-3-carboxamide 1,1-dioxide
基本信息
分子式
C13H10ClN3O4S2
分子量
371.83 g/mol
Physical Properties
熔点
230°C(dec.)(lit.)
沸点
No data available
密度
1.727
闪点
No data available
化学标识符
SMILES
CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3
InChIKey
WLHQHAUOOXYABV-UHFFFAOYSA-N
数据库引用
MDL号
MFCD00866163
常见问题
氯诺昔康是一种非甾体抗炎药(NSAID),化学结构包含噻吩并噻嗪环,带有氯、羟基、甲基和酰胺基团,同时有两个过氧化基团(1,1-二氧)。其分子式为C14H11ClN2O4S2,分子量为369.82 g/mol,具有较强的镇痛和抗炎活性,主要通过选择性抑制环氧化酶-2(COX-2)发挥药效。
氯诺昔康主要用于治疗风湿性关节炎、骨关节炎、痛风等炎症相关疾病,以及缓解术后疼痛、牙痛和肌肉骨骼疼痛。作为COX-2选择性抑制剂,它能有效减少炎症介质前列腺素的合成,同时降低对胃肠道的刺激风险,适用于需要长期抗炎治疗的患者。
氯诺昔康在推荐剂量下通常安全,但可能引起胃肠道不适、肝功能异常或过敏反应。使用时需避免与抗凝血药物联用,以防增加出血风险。操作人员应佩戴防护手套和护目镜,防止接触皮肤或吸入粉尘。若出现严重不良反应,应 immediately 停药并咨询医生。
氯诺昔康应储存于干燥、阴凉处,温度不超过25℃,相对湿度低于60%。需避光保存,建议使用棕色玻璃容器或铝箔包装袋密封。避免与强酸、强碱或氧化剂接触,远离热源和潮湿环境。储存期间应定期检查包装完整性,防止受潮或光照导致的降解。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序
联系信息
联系人
杨
邮箱
394537118@qq.com


![(2S,3S,4R,5R,6S)-6-[[(1S,2R,19R,22S,34S,37R,40R,52S)-5,32-dichloro-52-[3-(dimethylamino)propylcarbamoyl]-2,26,31,44,49-pentahydroxy-22-(methylamino)-21,35,38,54,56,59-hexaoxo-47-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,13,28-trioxa-20,36,39,53,55,58-hexazaundecacyclo[38.14.2.23,6.214,17.219,34.18,12.123,27.129,33.141,45.010,37.046,51]hexahexaconta-3,5,8,10,12(64),14(63),15,17(62),23(61),24,26,29(60),30,32,41(57),42,44,46(51),47,49,65-henicosaen-64-yl]oxy]-3,4-dihydroxy-5-(10-methylundecanoylamino)oxane-2-carboxylic acid](https://cnstatic.chemtradehub.com/structs/171/171500-79-1-998b.webp)


![Methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate](https://cnstatic.chemtradehub.com/structs/50-/50-55-5-8d3a.webp)

![4-{3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-methoxy-6-quinolinecarboxamide methanesulfonate (1:1)](https://cnstatic.chemtradehub.com/structs/857/857890-39-2-f557.webp)

![(2R,3R,4R,5R)-2-{[(1S,2S,4S,6R)-4,6-diamino-3-{[(3R,6S)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol](https://cnstatic.chemtradehub.com/structs/140/1405-41-0-4665.webp)